Video Experimental Relacionado
Updated: Aug 1, 2026
08:15
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
Investigación genómica: satisfacer las expectativas del público en cuanto al conocimiento y la comercialización
1National Institutes of Health, Bethesda, MD 20892.
Science (New York, N.Y.)
|August 14, 1992
Resumen
Este artículo examina la patentación de secuencias genéticas, explorando la evolución de la ley de patentes y sus efectos en la investigación académica y la transferencia de tecnología. La adopción cuidadosa de políticas es crucial para la investigación del genoma en medio de rápidos avances tecnológicos.
Área de la Ciencia:
- Derecho de la biotecnología Derecho de la biotecnología.
- Propiedad intelectual La propiedad intelectual.
- Investigación genómica en la investigación genómica.
Sus antecedentes:
- Contexto histórico de la patentación de la secuencia génica.
- Fundamentos y evolución del derecho de patentes.
- Visión general de la ley y la política federales de transferencia de tecnología.
Objetivo del estudio:
- Evaluar el impacto de la patentación de genes en la investigación académica.
- Examinar la patentabilidad de las secuencias de genes.
- Analizar la influencia de los datos de secuencia publicados en la protección de patentes de productos posteriores.
Principales métodos:
- Análisis histórico del derecho de patentes.
- Revisión de las políticas federales de transferencia de tecnología.
- Examen de las perspectivas de la industria y los registros públicos sobre la patentación de genes.
Principales resultados:
- La patentación de genes ha evolucionado significativamente, impactando la investigación académica y la transferencia de tecnología.
- La patentabilidad de las secuencias de genes presenta desafíos complejos, especialmente con los datos publicados.
- Las perspectivas de la industria y del público resaltan la necesidad de un cuidadoso desarrollo de políticas.
Conclusiones:
- Las políticas de transferencia de tecnología para la investigación del genoma requieren una implementación cuidadosa y adaptable.
- Equilibrar la innovación con el acceso es clave en el panorama en evolución de la patentación de genes.
- La solicitud de patente estratégica y la concesión de licencias son fundamentales para los avances genómicos.
Videos de Conceptos Relacionados
00:58Genomic DNA in Eukaryotes
Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
02:34DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...